DIA 2024 Global Annual Meeting

Attending this event?

DIA 2024 Global Annual Meeting

arrow_back View All Dates

7:00am PDT

Coffee and Light Refreshments Sails Pavilion DIA Annual Meeting Orientation Content Hub Sails Pav

8:00am PDT

#100: Opening Plenary and Keynote Address Ballroom

10:00am PDT

#SCC: Student Case Competition Sails Pavilion Coffee Break Exhibit Hall

10:15am PDT

#101 IT: Taimei Technology Innovation Theater: Next-Gen Trials Platform: AI-Native, Collaboration-First, and Site Network Exhibit Hall Theater #1 #102 IT: Appian Innovation Theater: AI in Life Sciences - Promise or Peril? Exhibit Hall Theater #2 #103 IT: Mendel AI Innovation Theater: RWD 2.0 - Decoding Patient Journeys at Scale through Clinical AI Exhibit Hall Theater #3

11:00am PDT

#104: Reporting of Pre-Market and Post-Market Safety Reports to FDA Adverse Event Reporting System (FAERS) Using ICH E2B R3 Standards Room 15AB #108: Risk Management in Advanced Device Technology Development Room 11AB #106: Machine Learning and Simulations to Facilitate Clinical Trials Room 5AB #107: Cloud-Driven Transformation: Empowering Pharma Industry and Regulators Room 6B #105: The Intersection of Science, Ethics, and Participant Collaboration in Pediatric Rare Disease Product Development Room 17AB #109: GCP Renovation: How Will GCP Inspection Change in Europe, Japan, and the US? Room 1AB #110: Modernizing CDER’s New Drugs Review Program (NDRP): A Progress Update Room 6F #111: China Town Hall Room 6D #112: Regulatory Convergence for CMC Requirements: The Challenges and Benefits of a Single Global Dossier Room 6C #113: Master Protocols: Integrating and Debating Clinical Trial Designs Room 2 #114: Breaking Boundaries: Overcoming Policy Crosstalk and Globalization Barriers to Foster Innovation Room 6E #115: From Intention to Action: Building Diversity, Equity, and Inclusion Initiatives to Create a Culture of Belonging Room 8 #116: Navigating the Trusted, Responsible, and Ethical Horizon of Artificial Intelligence: Uniting Healthcare Perspectives Room 6A

12:00pm PDT

#117 CH: Rare Diseases Multistakeholder Collaboration Towards Regulatory Endorsed Innovative Clinical Development Approach Content Hub Sails Pav Luncheon Service Exhibit Hall

12:15pm PDT

#119 IT: RWS Innovation Theater: Accelerate Time-to-Market with Smart, Structured Content, Reuse, and AI Exhibit Hall Theater #1 #120 IT: Datacubed Health Innovation Theater: The Impact of Digital Tools on Pediatric and Elderly Clinical Trials Exhibit Hall Theater #2 #121 IT: Castor Innovation Theater: Practical AI - Creating a Future Without Manual Data Re-Entry Exhibit Hall Theater #3 #118 RT: Roundtable Discussion: The Interaction of Science, Ethics, and Patient Collaboration in Pediatric Rare Disease Product Development Ballroom 20 Lobby #POS 1: Professional and Student Poster Session 1 Posters Exhibit Hall

12:45pm PDT

#122 CH: Digital Transformation: More Than Just Technology - Understanding How to Make it a Reality Content Hub Sails Pav

12:55pm PDT

#123 IT: IQVIA Innovation Theater: Evolving Clinical Development Approach Amidst a Digital Transformation Wave Exhibit Hall Theater #1 #124 IT: PPD, part of Thermo Fisher Scientific Innovation Theater: Accelerating Drug Development Through the Convergence of Real-World Data (RWD) and Technology Exhibit Hall Theater #2 #125 IT: Box Innovation Theater: From Data Chaos to Digital Clarity - Defining the Next Generation of Life Sciences with AI and eSignatures Exhibit Hall Theater #3

1:30pm PDT

#126 CH: AI Enhanced Contact Center: Risks to Consider for Medical and Patient Information Exchange Content Hub Sails Pav

1:35pm PDT

#127 IT: Deloitte Innovation Theater: Turning Vision into Reality - Realizing the Promise of Next-Gen Regulatory Intelligence Exhibit Hall Theater #1 #128 IT: Evernorth Health Services Innovation Theater: Analyzing Online Survey Responsiveness and Participation Exhibit Hall Theater #2 #129 IT: H1 Innovation Theater: Beyond the Numbers - Humanizing Data in Clinical Trials for Inclusive Healthcare Solutions Exhibit Hall Theater #3

2:15pm PDT

#132: The Cost of Moving the Needle on Clinical Trial Representation: Strategies for Diversity Budget Planning and Resourcing Room 5AB #133: ICH M11 Protocol Template: A Global Solution for Global Drug Development Room 17AB #131: Innovative Approaches to the Design of Pediatric Development Programs: What’s New in the Use of Pediatric Extrapolation Room 14AB #134: Shifting Medical Writing Value Propositions with the Use of Technology Tools Room 2 #135: Enhancing the Science of Patient Engagement and Patient Input: What's in the Future? Room 6B #138: Having the End in Mind When Building Quality into Clinical Trials: A Regulatory and Industry Perspective Room 6D #139: Comparative Perspectives on Regulating AI in Drug Development: US Versus EU Room 6C #140: The State of Real-World Evidence for Regulatory Decision-Making: Views from FDA, EMA, and PMDA Room 6F #137: Options to Consider When Balancing Risk, Timelines, Cost, and Patient Centricity While Meeting Project Optimus Guidelines Room 1AB #136: In Vitro Diagnostic/Companion Diagnostics Developments in the US and Impact on Global Programs Room 15AB #141: Innovation in Manufacturing Globally Room 11AB #142: Causal Inference Methodology in Drug Development Room 6E #130: Interactive Safety Graphics in the Regulatory Decision-Making Process Room 6A #143: Unveiling the Secrets of Success: An Executive Panel with Insights to Navigating your Career Journey Room 8

3:30pm PDT

#144: Paradigm Shift in Adverse Event Report Management and Sharing: The Case, The Need, and Possible Ways Forward Room 6C #145: Selective Safety Data Collection: As a Tool to Advance Clinical Trial Designs Room 5AB #147: Data and Technology Influence on ICH Initiatives: M4Q(r2)/Q12 and Global Harmonization Room 6B #148: Navigating the Regulatory Landscape: Real-World Data and Real-World Evidence in Regulatory Documents Room 7AB #149: Effective Patient / Industry Collaboration: Valuing Patient Lived Experience To Inform Trial Design Room 6F #150: Building Trust in New Alternative Methods in Investigational New Drug Applications Room 1AB #152: Innovative Alternative Approaches to Evaluating GCP During the COVID-19 Public Health Emergency and Beyond Room 17AB #153: Designing your Regulatory Intelligence Framework: Powered by Artificial Intelligence and Critical Thinking Room 15AB #154: Impact of Accelerated Pathways on Patients in Five Countries/Regions Room 11AB #155: Health Canada Town Hall Room 6D #146: Past, Present, and Future: How Industry and FDA are Handling the Evolving Clinical Trial Diversity Regulatory Landscape Room 6A #156: Data Insight Generation: Leveraging Data Visualization in Study Planning, Monitoring, Exploration, Reporting, and Submission Room 6E #157: Be Creative and Innovative: A Simple Step-by-Step Process for You and Your Team Room 8 #151: Elevate Leadership: Harnessing the Five Superpowers Room 2

4:45pm PDT

#158 IT: InSilicoTrials Technologies Innovation Theater Exhibit Hall Theater #1 #160 IT: Certara Innovation Theater: Technology-Enabled Writing - Use CoAuthor™ as your Fully Integrated GenAI Medical Writing Platform Exhibit Hall Theater #3